GAN and cystic fibrosis: Ongoing clinical trials on patients with cystic fibrosis (IGNITE study, ClinicalTrials.gov Identifier: NCT02354859) will provide important insights into P. aeruginosa inhibition during i.v. GaN treatment of chronic lung infection, hence on the actual potential of Ga(III) as an antibacterial agent.